logo
SGH achieves remarkable milestone: Five hospitals granted 5-star rating by Newsweek's Global Hospital Rating

SGH achieves remarkable milestone: Five hospitals granted 5-star rating by Newsweek's Global Hospital Rating

Zawya23-07-2025
Saudi German Health (SGH), a leading healthcare group in the Middle East and North Africa (MENA) region, has reinforced its industry leadership with five of its hospitals in Saudi Arabia earning five-star ratings in Newsweek's Global Hospital Rating. The hospitals in Riyadh, Makkah, Madinah, Aseer, and Jeddah all received this rating, establishing SGH as the healthcare group with the most five-star-rated hospitals in the region.
This latest milestone reinforces SGH's unwavering commitment to providing top-patient-centred healthcare, while upholding high clinical standards and embracing innovative healthcare solutions. It also reflects SGH's ongoing efforts to align with Saudi Arabia's ambitious Vision 2030 goals, which aim to improve quality of life and elevate the Kingdom's healthcare sector to global standards.
Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, said: 'We are proud to be recognised once again as the healthcare group with the highest number of five-star-rated hospitals in the region. This achievement is a testament to our dedication to clinical excellence, innovation, and exceptional service. It is not the first time we lead the region with such accomplishments — earlier this year, we were also honoured with having the highest number of top-ranked hospitals in the region in Newsweek's World's Best Hospitals 2025 list. These achievements reflect our strong leadership, our proud Saudi identity, and our alignment with Vision 2030's healthcare transformation goals.'
These recognitions by Newsweek emphasise SGH's role as a pioneer of healthcare excellence in the Kingdom and the wider region. By consistently meeting the highest international standards and achieving outstanding results, Saudi German Health continues to influence the future of healthcare across Saudi Arabia and beyond.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Smaller portions and high-protein, the 'Ozempic menu' has arrived in Dubai
Smaller portions and high-protein, the 'Ozempic menu' has arrived in Dubai

The National

time7 hours ago

  • The National

Smaller portions and high-protein, the 'Ozempic menu' has arrived in Dubai

A Dubai restaurant has introduced a high-protein, smaller-portion menu designed specifically for people using weight-loss injections. Mediterranean restaurant The Banc Dubai says its Mini Bancer menu comprises of their most popular dishes and drinks, but reimagined as lighter and "more intentional" portions. Highlights include a half-sized grilled sea bream and barbecue melt chicken, alongside scaled-down starters, which include lamb kebab, tiger prawns and wagyu beef tartare. Dessert classics also come in petite portions, from baklava bites to half-sized apple pie. GLP-1 drugs, marketed under brand names such as Ozempic, Mounjaro and Wegovy, work by slowing digestion and signalling the brain to promote a feeling of fullness, which can lead to reduced appetite and weight loss. The Banc Dubai says their new menu was first trialed at their London location before being introduced in the UAE. "People are still dining out – they're just arriving less hungry," says Mazlum Topcu, co-founder of The Banc. "What this new guest really wants is the chance to eat less without drawing attention to it in front of the whole restaurant. 'Some diners don't want to admit they're on the jab. They'll order a big spread, push food around their plate and hope someone else does the heavy lifting. The funny thing is that half the table is probably doing the same thing – so you end up with too much food and unnecessary waste. Our approach makes it easier for everyone to eat the way they want, without the fuss." While it might be new to the UAE, The Banc Dubai is not the first to introduce a so-called "Ozempic menu" as an increasing number of GLP-1 users say they are dining out less. Earlier this year, a survey of 1,000 GLP-1 users in the US by Bloomberg Intelligence found 54 per cent of respondents said they dined out significantly less or less frequently since starting the medication. About the same percentage reported ordering less takeout. In a Morgan Stanley survey in April last year, about two-thirds of GLP-1 users said they spent less money at restaurants, while 31 per cent said they cut back on groceries. Clinton Hall, a group of burger and beer restaurants in New York City known for large portions, recently introduced a Teeny Weeny Mini Meal that includes a petite hamburger, a few fries and a small beer. 'It 100 per cent is targeting the growing number of GLP-1 users,' Greg Mecane, the group's marketing director told While not specifically targeted at GLP-1 users, international chain The Cheesecake Factory also has a "SkinnyLicious" menu, including at its UAE branches, which features smaller sizes and lower calorie dishes. At Town restaurant in London, which opened in May, diners can order half-portions of selected main menu items, as well as desserts. 'We absolutely design dishes specifically for the Mounjaro generation,' owner Jonathan Downey told The Times. "We thought we were just giving people more options, but it turns out to be part of the zeitgeist." And the popularity of these drugs is only set to grow, with Morgan Stanley analysts estimating the market for GLP-1s to be worth $105 billion by 2030. They also estimate that 31.5 million people will take GLP-1s by 2035.

A Global Milestone: Dr. Soliman Fakeeh Hospital in Jeddah receives accreditation for 14 centers of excellence from SRC
A Global Milestone: Dr. Soliman Fakeeh Hospital in Jeddah receives accreditation for 14 centers of excellence from SRC

Zawya

time8 hours ago

  • Zawya

A Global Milestone: Dr. Soliman Fakeeh Hospital in Jeddah receives accreditation for 14 centers of excellence from SRC

In a remarkable and unprecedented global achievement that adds to its legacy of excellence, Dr. Soliman Fakeeh Hospital in Jeddah has been awarded accreditation for 14 Centers of Excellence by the Surgical Review Corporation (SRC) across various medical and surgical specialties—setting a world record for the highest number of Centers of Excellence accredited by SRC within a single hospital. This prestigious international recognition reflects the hospital's deep commitment to implementing 10 rigorous global standards, ensuring the delivery of safe, comprehensive, and high-quality patient care. The accredited specialties include: 1. Robotic Surgery 2. Urology 3. Orthopedic Surgery 4. Spine Surgery 5. Surgery of the Hand 6. Colorectal Surgery 7. Hernia Surgery 8. Plastic Surgery 9. Endoscopy 10. Ear, Nose & Throat (ENT) 11. Ophthalmology 12. Minimally Invasive Gynecology 13. ⁠Specialized Anesthesia in Obesity Surgery 14. Specialized Anesthesia in Orthopedic Surgery These accreditations are based on the hospital's adherence to ten rigorous global standards developed by SRC for Centers of Excellence. These include institutional commitment with a clear vision and a quality-first culture, certified medical expertise from highly qualified physicians with outstanding surgical records, trusted medical leadership to oversee program efficiency, and comprehensive consultative services with ongoing medical support for all medical and surgical cases. Additional standards include the use of state-of-the-art equipment and advanced technology with fully trained staff, the availability of a qualified and dedicated medical and surgical teams with consistent on-call coverage, the application of standardized clinical pathways with precise protocols to ensure optimal care, and well-trained support teams including program coordinators, nurses, assistants, and specialized surgical staff. Patient education is also prioritized through the provision of clear information and the obtaining of informed consent for all procedures with a shared decision-making approach. There is also a firm commitment to ongoing quality evaluation, outcome monitoring, and full compliance with data protection regulations. Dr. Mazen Fakeeh, President of Fakeeh Care Group, expressed his pride in this exceptional global achievement, reaffirming the hospital's commitment to delivering specialized, world-class healthcare that meets patients' expectations and supports the vision of Fakeeh Care Group for excellence, leadership, and innovation in healthcare. It's worth noting that the Surgical Review Corporation (SRC) is an independent, global, non-profit organization dedicated to accrediting hospitals, surgeons, and surgical centers according to the highest standards of quality and patient safety. The Center of Excellence designation is awarded only after a comprehensive and rigorous evaluation process that ensures healthcare services are advanced, safe, and aligned with the best global medical practices.

Dubai Strengthens Its Role as a Leading Hub for Dermatology with the 10th International MEIDAM Congress
Dubai Strengthens Its Role as a Leading Hub for Dermatology with the 10th International MEIDAM Congress

Web Release

time8 hours ago

  • Web Release

Dubai Strengthens Its Role as a Leading Hub for Dermatology with the 10th International MEIDAM Congress

The 10th International Congress of Medical Excellence in Dermatology and Aesthetic Medicine (MEIDAM 2025) will be held from 25 to 27 September 2025 at the Dubai World Trade Centre (DWTC), bringing together dermatologists, aesthetic medicine specialists and healthcare professionals from more than 90 countries. Organised by DXB LIVE, the integrated event management and experiential agency of Dubai World Trade Centre, in partnership with the MEIDAM Association, this year's milestone edition reinforces Dubai's position as a global destination for world-class medical congresses and scientific exchange. Marking a decade of continuous growth, MEIDAM Congress has evolved into one of the most important international gatherings in its field. This milestone edition will place a strong spotlight on the latest breakthroughs in artificial intelligence (AI) and other emerging technologies that are transforming the practice of dermatology and aesthetic medicine worldwide. 'Reaching the 10-year milestone is a proud moment for MEIDAM and a reflection of how the congress has evolved over the past decade,' said Dr. Khaled Al Nuaimi, President of MEIDAM Congress and the MEIDAM Association. 'Dubai's position as a world-class host city has allowed MEIDAM to flourish, bringing together leading minds to discuss how innovation, particularly AI, is shaping the future of our field. This year's program will be our most dynamic yet.' Commenting on the importance of hosting MEIDAM 2025 and other leading medical congresses in Dubai, Khalid Al Hammadi, Senior Vice President of DXB LIVE at Dubai World Trade Centre, said: 'Hosting a medical congress of this scale and significance reaffirms Dubai's status as the region's premier destination for international events and specialised conferences that attract top experts and professionals from across disciplines. Organising such events not only supports the advancement of the healthcare sector but also promotes knowledge exchange and keeps pace with global trends in vital fields such as dermatology and aesthetic medicine.' The 2025 congress will feature its largest scientific program to date, with more than 90 sessions and over 300 lectures, allowing delegates to gain exclusive insights into AI-driven diagnostic tools, personalised treatment strategies, advances in regenerative medicine, and other emerging technologies that are redefining patient care. Participation is expected to reach record levels, with leading organisations including the American Academy of Dermatology (AAD), the International League of Dermatological Societies (ILDS), the European Academy of Dermatology and Venereology (EADV), the Royal College of Physicians (RCP) UK, the World Health Organisation (WHO), and the United Nations High Commission for Refugees (UNHCR) confirmed to attend. Dermatological societies from the MENA region, Asia, Europe, North Americas, and Africa will also take part, building on the success of MEIDAM Africa, which was held for the first time in Morocco earlier this year. 'As MEIDAM enters its second decade, we are focused on expanding the congress' global reach and influence,' said Dr. Saad Al Sogair, Secretary General, Treasurer and Head of the Executive Committee of MEIDAM Congress. 'Dubai has proven itself as a key international hub for medical knowledge and innovation, and MEIDAM is proud to contribute to that growth while providing unmatched opportunities for learning and collaboration.' In addition to the scientific sessions, an extensive industry exhibition will bring together leading international and regional companies showcasing the latest pharmaceuticals, devices and technologies set to shape the future of dermatology and aesthetic medicine. Since its inception, MEIDAM has become the largest and most academically rigorous dermatology congress in the region, attracting top clinicians, researchers and industry leaders from around the world. The 10th edition will build on this legacy, further strengthening Dubai's reputation as a trusted host for major international medical congresses. For registration and programme details, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store